GlobeImmune, Inc. (GBIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Apr 16, 2026
GlobeImmune Market Cap
GlobeImmune has a market cap or net worth of $575.00 as of April 29, 2026. Its market cap has decreased by -99.97% in one year.
Market Cap
575.00
Enterprise Value
n/a
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 2, 2014, GlobeImmune's market cap has decreased from 60.99M to 575.00, a decrease of -100.00%. That is a compound annual growth rate of -62.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adynxx | 581.00 |
| Mera Pharmaceuticals | 537.00 |
| Tetra Bio-Pharma | 516.00 |
| Pathfinder Cell Therapy | 667.00 |
| Alzex Neuropharma | 753.00 |
| RegeneRx Biopharmaceuticals | 754.00 |
| Biora Therapeutics | 885.00 |
| eFFECTOR Therapeutics | 941.00 |